US EditionPublished • loading... • Updated
Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears
Summary by The Motley Fool
1 Articles
1 Articles
Maze Therapeutics President Sells All Insider Shares as Q4 Earning Report Nears
Key PointsOne of Maze Therapeutics' executives exercised and sold 30,000 shares on March 10, 2026, generating gross proceeds of ~$1.51 million at a weighted-average price of ~$50.45 per share.Bernstein retains 267,407 shares in stock options, which can be converted to Common Stock.10 stocks we like better than Maze Therapeutics › On March 10, 2026, Harold Bernstein, President, R&D & Chief Medical Officer of Maze Therapeutics (NASDAQ:MAZE), repor…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
